Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49.

Article  PubMed  Google Scholar 

Whitburn J, Rao SR, Morris EV, Tabata S, Hirayama A, Soga T, Edwards JR, Kaya Z, Palmer C, Hamdy FC, et al. Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival. Sci Adv. 2022;8(8):eabf9096.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alibhai SMH, Breunis H, Feng G, Timilshina N, Hansen A, Warde P, Gregg R, Joshua A, Fleshner N, Tomlinson G, et al. Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 with cognitive function in older men with metastatic castration-resistant prostate Cancer. JAMA Netw Open. 2021;4(7):e2114694.

Article  PubMed  PubMed Central  Google Scholar 

McAllister MJ, Underwood MA, Leung HY, Edwards J. A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer. Transl Res. 2019;206:91–106.

Article  CAS  PubMed  Google Scholar 

Pucci P, Rescigno P, Sumanasuriya S, de Bono J, Crea F. Hypoxia and noncoding RNAs in Taxane Resistance. Trends Pharmacol Sci. 2018;39(8):695–709.

Article  CAS  PubMed  Google Scholar 

Maloney SM, Hoover CA, Morejon-Lasso LV, Prosperi JR. Mechanisms of Taxane Resistance. Cancers (Basel) 2020, 12(11).

Galletti G, Leach BI, Lam L, Tagawa ST. Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer. Cancer Treat Rev. 2017;57:16–27.

Article  CAS  PubMed  Google Scholar 

Payne H, Cornford P. Prostate-specific antigen: an evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer. Urol Oncol. 2011;29(6):593–601.

Article  PubMed  Google Scholar 

Balacescu O, Dumitrescu RG, Marian C. MicroRNAs role in prostate Cancer. Methods Mol Biol. 2018;1856:103–17.

Article  PubMed  Google Scholar 

Cao H, Wang D, Sun P, Chen L, Feng Y, Gao R. Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis. Aging. 2021;13(19):23096–107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xing Z, Li S, Xing J, Yu G, Wang G, Liu Z. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis. Lab Invest. 2022;102(6):602–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan X, Song X, Fan B, Li M, Zhang A, Pei L. Exosomal circRNA scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway. Anticancer Drugs. 2022;33(9):871–82.

Article  CAS  PubMed  Google Scholar 

Sun Y, Chen G, He J, Huang ZG, Li SH, Yang YP, Zhong LY, Ji SF, Huang Y, Chen XH, et al. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer. Bioengineered. 2021;12(1):325–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abudoubari S, Bu K, Mei Y, Maimaitiyiming A, An H, Tao N. Preliminary study on miRNA in prostate cancer. World J Surg Oncol. 2023;21(1):270.

Article  PubMed  PubMed Central  Google Scholar 

Enwald M, Lehtimäki T, Mishra PP, Mononen N, Murtola TJ, Raitoharju E. Human prostate tissue MicroRNAs and their predicted target pathways linked to prostate Cancer risk factors. Cancers (Basel) 2021, 13(14).

Wang WT, Han C, Sun YM, Chen TQ, Chen YQ. Noncoding RNAs in cancer therapy resistance and targeted drug development. J Hematol Oncol. 2019;12(1):55.

Article  PubMed  PubMed Central  Google Scholar 

Samli H, Samli M, Vatansever B, Ardicli S, Aztopal N, Dincel D, Sahin A, Balci F. Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines. World J Urol. 2019;37(6):1117–26.

Article  CAS  PubMed  Google Scholar 

Egidi MG, Cochetti G, Serva MR, Guelfi G, Zampini D, Mechelli L, Mearini E. Circulating microRNAs and kallikreins before and after radical prostatectomy: are they really prostate cancer markers? Biomed Res Int. 2013;2013:241780.

Article  PubMed  PubMed Central  Google Scholar 

Lin HM, Castillo L, Mahon KL, Chiam K, Lee BY, Nguyen Q, Boyer MJ, Stockler MR, Pavlakis N, Marx G, et al. Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer. Br J Cancer. 2014;110(10):2462–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin HM, Mahon KL, Spielman C, Gurney H, Mallesara G, Stockler MR, Bastick P, Briscoe K, Marx G, Swarbrick A, et al. Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer. Br J Cancer. 2017;116(8):1002–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zedan AH, Osther PJS, Assenholt J, Madsen JS, Hansen TF. Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer. Sci Rep. 2020;10(1):227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr., Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351(15):1513–20.

Article  CAS  PubMed  Google Scholar 

Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351(15):1502–12.

Article  CAS  PubMed  Google Scholar 

Pan Y, Yu H, Lu F. TRIM11 Posttranscriptionally modulated by miR-5193 facilitates tumor growth and metastasis of prostate Cancer. Technol Cancer Res Treat. 2023;22:15330338231178639.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy RM, Watt KK, Cameron-Smith D, Gibbons CJ, Snow RJ. Effects of creatine supplementation on housekeeping genes in human skeletal muscle using real-time RT-PCR. Physiol Genomics. 2003;12(2):163–74.

Article  CAS  PubMed  Google Scholar 

Zhang W, Song C, Ren X. Circ_0003998 regulates the progression and Docetaxel Sensitivity of DTX-Resistant Non-small Cell Lung Cancer cells by the miR-136-5p/CORO1C Axis. Technol Cancer Res Treat. 2021;20:1533033821990040.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang X, Wang Z, Hou S, Yue C, Li Z, Hu W, Lu H. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. Bioengineered. 2022;13(2):4153–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Y, Zheng S, Lin Y, Ke L. Circular RNA circ-ERBB2 elevates the Warburg Effect and facilitates triple-negative breast Cancer Growth by the MicroRNA 136-5p/Pyruvate dehydrogenase kinase 4 Axis. Mol Cell Biol. 2021;41(10):e0060920.

Article  PubMed  Google Scholar 

Liang M, Yao W, Shi B, Zhu X, Cai R, Yu Z, Guo W, Wang H, Dong Z, Lin M, et al. Circular RNA hsa_circ_0110389 promotes gastric cancer progression through upregulating SORT1 via sponging mir-127-5p and miR-136-5p. Cell Death Dis. 2021;12(7):639.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin C, Wang A, Liu L, Wang G, Li G. Hsa_circ_0136666 promotes the proliferation and invasion of colorectal cancer through miR-136/SH2B1 axis. J Cell Physiol. 2019;234(5):7247–56.

Article  CAS  PubMed  Google Scholar 

Liu J, Huang Y, Zhu D, Dai Y, Liu D, Zhai Y, Liang X, Wu L, Zhao Q. Establishment and ch